HHE Haematology supplement 2018 - Page 24

haematology and oncology Implications of licensed standardised chemotherapy doses and their potential impact The introduction of dose banding and the recent publication of product specifications by NHS England have set the ball in motion for the introduction of licensed standardised chemotherapy doses, the benefits of which are discussed here Tariro Kabba MRPharmS DipGPP Principal Pharmacist Cancer and Aseptics Christopher Woodard Lead Technician and Aseptics Manager Milton Keynes University Hospital NHS Trust, UK Chemotherapy is the single biggest service area-spend within NHS England specialised commissioning. In 2016/17, NHS England spent approximately £1.7 billion on the routine commissioning of chemotherapy, with drug costs accounting for the largest proportion (80%). 1 In 2015 Lord Carter published a report 2 on productivity and efficiency in the NHS, identifying £5bn of efficiency opportunities resulting from unwarranted variation. The report outlined that potential savings could be made within the NHS, by improving workflow systems. The hospital pharmacy and medicines optimisation programme (HopMOp) was initiated following the recommendations of Lord Carter and it has undertaken various projects to be able 24 HHE 2018 | hospitalhealthcare.com to deliver the efficiency targets as set out in the report. Since 2016, NHS Trusts in England have seen the introduction of chemotherapy dose standardisation through dose banding. Dose banding is the process by which calculated drug doses are grouped and set to a pre-defined dose. Each series of consecutive doses is the ‘band’ and the dose that they are rounded towards is the ‘banded dose’. 3 Dose banding was launched for an initial 19 commonly used chemotherapy drugs to help the NHS achieve value through the ability to purchase standard off-the-shelf products. 1 The NHS Pharmaceutical Quality Assurance Committee and the British Oncology Pharmacy Association (BOPA) have published a guide on sourcing ready to administer chemotherapy. 3